Junyi Duan

923 total citations · 1 hit paper
19 papers, 665 citations indexed

About

Junyi Duan is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Junyi Duan has authored 19 papers receiving a total of 665 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 7 papers in Molecular Biology and 6 papers in Epidemiology. Recurrent topics in Junyi Duan's work include HIV/AIDS Research and Interventions (6 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and CRISPR and Genetic Engineering (4 papers). Junyi Duan is often cited by papers focused on HIV/AIDS Research and Interventions (6 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and CRISPR and Genetic Engineering (4 papers). Junyi Duan collaborates with scholars based in China, United States and Australia. Junyi Duan's co-authors include Xinlin Lei, Hao Yin, Ying Zhang, Shuhan Lu, Qiubing Chen, Yizhou Zhang, Yang Qiu, Xi Zhou, Muhan Huang and Dingyu Zhang and has published in prestigious journals such as Cell, Molecular Cell and Nature Methods.

In The Last Decade

Junyi Duan

15 papers receiving 651 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fast and sensitive detection of SARS-CoV-2 RNA using suboptimal protospacer adjacent motifs for Cas12a

2022 272 citations Shuhan Lu, Kun Zhang et al. Nature Biomedical Engineering profile →

Peers

Countries citing papers authored by Junyi Duan

Since Specialization

Citations

This map shows the geographic impact of Junyi Duan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junyi Duan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junyi Duan more than expected).

Fields of papers citing papers by Junyi Duan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junyi Duan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junyi Duan. The network helps show where Junyi Duan may publish in the future.

Co-authorship network of co-authors of Junyi Duan

This figure shows the co-authorship network connecting the top 25 collaborators of Junyi Duan. A scholar is included among the top collaborators of Junyi Duan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junyi Duan. Junyi Duan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Targeting CTGF overcomes resistance to CSF1R inhibitors by preventing CAF activation in colorectal cancer 2025 ·Cell Reports Medicine ·Bojun Wang, (unknown), (unknown), (unknown), (unknown), Shuling Han, (unknown), Xin Guan, Rui Yang, (unknown), Tong Wu, Zhuo Chen, Junyi Duan, (unknown), Yanqiao Zhang, Chao Liu	0
2	Effectiveness of an HIV peer support precision matching platform: a randomized controlled trial protocol 2024 ·BMC Public Health ·(unknown), Shuyu Han, Yangfeng Wu, Tao Huang, Junyi Duan, Dongmei Li, (unknown), Bo Zhou, (unknown), Lili Zhang	0
3	Human mpox co-infection with advanced HIV-1 and XDR-TB in a MSM patient previously vaccinated against smallpox: A case report 2024 ·Biosafety and Health ·(unknown), (unknown), Taiyi Jiang, Junyi Duan, Tao Huang, Hao Liu, (unknown), (unknown), (unknown), Mei Zhang, Wen Wang, Caiping Guo, Lifeng Liu, Yuening Zhang, Tong Zhang	0
4	Global perspectives on smallpox vaccine against monkeypox: a comprehensive meta-analysis and systematic review of effectiveness, protection, safety and cross-immunogenicity 2024 ·Emerging Microbes & Infections ·Hao Liu, Wenjing Wang, Yang Zhang, (unknown), Junyi Duan, Tao Huang, (unknown), Tong Zhang	8
5	Amplification editing enables efficient and precise duplication of DNA from short sequence to megabase and chromosomal scale 2024 ·Cell ·Ruiwen Zhang, (unknown), (unknown), (unknown), (unknown), Guoquan Wang, (unknown), Pan Gao, Ying Wu, Shuhan Lu, Junyi Duan, S. F. Sun, Na Yang, Wei Fan, Kaitao Zhao, Bei Yang, (unknown), Yan Zhang, Ying Zhang, Hao Yin	15
6	Severe acute respiratory syndrome coronavirus 2-specific T-cell responses are induced in people living with human immunodeficiency virus after booster vaccination 2024 ·Chinese Medical Journal ·Xiuwen Wang, Yongzheng Li, (unknown), Xiaoran Chai, Zhenglai Ma, Junyi Duan, Guanghui Zhang, (unknown), Xin Zhang, Tong Zhang, Hao Wu, Yunlong Cao, Bin Su	4
7	Effectiveness and safety of community-led assisted partner service among HIV-diagnosed men who have sex with men: a multicentre, randomized controlled trial in China 2023 ·The Lancet Regional Health - Western Pacific ·(unknown), Fan Liu, Zhenxing Chu, Junyi Duan, (unknown), Jiaxin Zheng, (unknown), Haibo Ding, Yongjun Jiang, Junjie Xu, Qinghai Hu, Hong Shang	0
8	Durable natural killer cell response after three doses of SARS-CoV-2 inactivated vaccine in HIV-infected individuals 2023 ·Chinese Medical Journal ·Xiaodong Yang, Xiuwen Wang, Xin Zhang, Haifeng Ding, Hu Wang, Tao Huang, Guanghui Zhang, Junyi Duan, Wei Xia, Bin Su, (unknown), Hao Wu, Tong Zhang	3
9	Weak SARS-CoV-2-specific responses of TIGIT-expressing CD8+ T cells in people living with HIV after a third dose of a SARS-CoV-2 inactivated vaccine 2023 ·Chinese Medical Journal ·(unknown), Xiuwen Wang, Yongzheng Li, Xiaodong Yang, Hu Wang, Xiaoxu Han, (unknown), Zhenglai Ma, Junyi Duan, Guanghui Zhang, (unknown), Tong Zhang, Hao Wu, Xin Zhang, Bin Su	4
10	DNA topology regulates PAM-Cas9 interaction and DNA unwinding to enable near-PAMless cleavage by thermophilic Cas9 2022 ·Molecular Cell ·(unknown), (unknown), (unknown), (unknown), (unknown), Caixiang Zhang, Yizhou Zhang, (unknown), Junyi Duan, (unknown), Xinlin Lei, Hao Yin, (unknown), (unknown)	26
11	Fast and sensitive detection of SARS-CoV-2 RNA using suboptimal protospacer adjacent motifs for Cas12a breakdown → 2022 ·Nature Biomedical Engineering ·Shuhan Lu, (unknown), (unknown), Kun Zhang, Yizhou Zhang, Qiubing Chen, Junyi Duan, Xinlin Lei, Muhan Huang, Yang Qiu, Dingyu Zhang, Xi Zhou, Ying Zhang, Hao Yin	272
12	Efficient targeted insertion of large DNA fragments without DNA donors 2022 ·Nature Methods ·Jinlin Wang, (unknown), Guoquan Wang, Ruiwen Zhang, Junyi Duan, Pan Gao, Xinlin Lei, Hou-Yuan Qiu, Zhang Chuan-ping, Ying Zhang, Hao Yin	113
13	Incidence Trends of Five Common Sexually Transmitted Infections Excluding HIV From 1990 to 2019 at the Global, Regional, and National Levels: Results From the Global Burden of Disease Study 2019 2022 ·Frontiers in Medicine ·Leiwen Fu, Yinghui Sun, Min Han, Bingyi Wang, Fei Xiao, Yiguo Zhou, Yanxiao Gao, Thomas Fitzpatrick, Tanwei Yuan, Peiyang Li, Yuewei Zhan, Yong Lü, Ganfeng Luo, Junyi Duan, Zhongsi Hong, Christopher K. Fairley, Tong Zhang, Jin Zhao, Huachun Zou	58
14	Comparing Immune Responses to Inactivated Vaccines against SARS-CoV-2 between People Living with HIV and HIV-Negative Individuals: A Cross-Sectional Study in China 2022 ·Viruses ·Xiaojie Huang, Ying Yan, Bin Su, Dong Xiao, Maohe Yu, Xia Jin, Junyi Duan, Xiangjun Zhang, Zheng Shi-min, Yuan Fang, Tong Zhang, Weiming Tang, Lunan Wang, Zixin Wang, Junjie Xu	34
15	Salient Constructs for the Development of Shared Decision-Making Tools for HIV Pre-Exposure Prophylaxis Uptake and Regimen Choice: Behaviors, Behavioral Skills, and Beliefs 2021 ·AIDS Patient Care and STDs ·Kathrine Meyers, Yumeng Wu, (unknown), Jianhua Hou, Qinghai Hu, Junyi Duan, Yao Li, Xiaoqing He	10
16	Salivary microbial diversity at different stages of human immunodeficiency virus infection 2021 ·Microbial Pathogenesis ·(unknown), Wei Xia, Feili Wei, Wei Feng, Junyi Duan, (unknown), (unknown), Yan Wang, (unknown), Jie Cao, Weidi Li, (unknown), Shan Guo, Fengqiu Zhang, Xiaojie Huang, Zheng Sun	8
17	The Underrated Salivary Virome of Men Who Have Sex With Men Infected With HIV 2021 ·Frontiers in Immunology ·(unknown), Xiaojie Huang, (unknown), (unknown), Yan Wang, (unknown), Jie Cao, (unknown), Yuchen Li, Xin Wang, Siyu Cai, Wei Xia, Feili Wei, Junyi Duan, (unknown), Shan Guo, Fengqiu Zhang, (unknown), (unknown)	5
18	Rapid detection of African swine fever virus using Cas12a-based portable paper diagnostics 2020 ·Cell Discovery ·Shuhan Lu, Fang Li, Qiubing Chen, Jing Wu, Junyi Duan, Xinlin Lei, Ying Zhang, Dongming Zhao, Zhigao Bu, Hao Yin	98
19	Consensus statement on human immunodeficiency virus pre-exposure prophylaxis in China 2020 ·Chinese Medical Journal ·Junjie Xu, Xiaojie Huang, Xinchao Liu, Liming Wang, (unknown), Hui Wang, Fujie Zhang, Hao Wu, Taisheng Li, Mengjie Han, Fang Zhao, Haibo Ding, Junyi Duan, (unknown), Hong Shang	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact